Avidity Biosciences, Inc. (RNA)
71.26
-0.37
(-0.52%)
USD |
NASDAQ |
Dec 08, 16:00
71.07
-0.19
(-0.27%)
After-Hours: 05:38
Avidity Biosciences Shareholders Equity (Quarterly): 1.886B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 44.33B |
| Eli Lilly & Co. | 23.79B |
| Dyne Therapeutics, Inc. | 691.78M |
| Astria Therapeutics, Inc. | 233.25M |
| Intellia Therapeutics, Inc. | 748.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.134B |
| Total Liabilities (Quarterly) | 247.94M |
| Debt to Equity Ratio | 0.0265 |
| Current Ratio | 11.57 |
| Net Debt Paydown Yield | -0.13% |